Following U.S. Stocks may claim a “BIG Change,” in the course of current trading session: Tempur Sealy International Inc (NYSE:TPX), Teva Pharmaceutical Industries (ADR) (NYSE:TEVA), Auspex Pharmaceuticals Inc (NASDAQ:ASPX), Cablevision Systems Corporation (NYSE:CVC)

• Tempur Sealy International Inc (NYSE:TPX), with shares incline 2.00% is now trading at $58.76. The Stock is active as 26,412.00 shares changed hands versus its average volume of 703,517.00 shares.

• Teva Pharmaceutical Industries (ADR) (NYSE:TEVA), with shares raised 0.50% is now trading at $62.83. The Stock is active as 716,279.00 shares changed hands versus its average volume of 4.77M shares.

• Auspex Pharmaceuticals Inc (NASDAQ:ASPX) with shares dipped -0.02% is now trading at $100.34. The Stock is active as 432,521.00 shares changed hands versus its average volume of 586,121.00 shares.

• Cablevision Systems Corporation (NYSE:CVC) with shares rose 0.05% is now trading at $18.49. The Stock is active as 318,384.00 shares changed hands versus its average volume of 2.79M shares.

Latest NEWS regarding these Stocks are depicted underneath:

Tempur Sealy International Inc (NYSE:TPX)

Tempur Sealy International Inc (TPX) - In an SEC filing, the mattress maker said it had received the request by shareholder H Partners to examine its books and will respond “in accordance with Delaware law.” The filing also criticizes the “refusal” of H Partners “to talk about its views with us.” H Partners has, among other things, called for the removal of the company’s CEO.

Tempur Sealy International, Inc., along with its subsidiaries, develops, manufactures, markets, and distributes bedding products worldwide. It operates through two segments, North America and International. The company offers mattresses, foundations, and adjustable bases, in addition to other products comprising pillows and other accessories.

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) & Auspex Pharmaceuticals Inc (NASDAQ:ASPX)

Oppenheimer upgraded Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)‘s shares to “outperform” from “perform” following the declaration that Teva will buy (ASPX). Oppenheimer said the deal gives Teva a desirable target, and that it signals that Teva will no longer be “viewed as a partner of last resort.”

Furthermore, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) declares the launch of the generic equivalent to Exforge® (amlodipine and valsartan) Tablets in four different strengths, in the United States.

Exforge® (amlodipine and valsartan) Tablets are used in the treatment of high blood pressure (hypertension), a chronic condition often without symptoms that is linked to serious health issues such as heart disease and stroke, if not detected early and treated appropriately. With the launch of Amlodipine and Valsartan Tablets, Teva can offer those prescribed Exforge® a generic alternative to help manage their high blood pressure.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products international. The company works in two segments, Generic Medicines and Specialty Medicines and Auspex Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing novel medicines for the treatment of orphan diseases. The company’s product candidates are used to address medical needs primarily in hyperkinetic movement disorders, such as chorea associated with Huntington’s disease, tardive dyskinesia, and Tourette syndrome, as well as other orphan indications.

Cablevision Systems Corporation (NYSE:CVC)

According to Reuters , Cablevision Systems Corporation (CVC) will offer $1 to buy the New York Daily News this week. Last month, owner Mort Zuckerman hired Lazard to assist with consideration of a possible sale.

Cablevision Systems Corporation, along with its subsidiaries, owns and works cable systems in the United States. The company works through three segments: Cable, Lightpath, and Other.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.